Company research
CNL Healthcare Properties, Inc.
CIK 1496454Updated Sep 24, 2026
Securities
Historical securities (1)
CHTH · OTC · equity · closed Feb 24, 2026Name history
CNL Healthcare Trust, Inc. · through Dec 21, 2012CNL Properties Trust, Inc. · through Dec 20, 2011CNL Diversified Lifestyle Properties, Inc. · through Oct 20, 2010
CHTH price & chart
Historical security
This listing closed Feb 24, 2026. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
4 filing
15-12G filing
S-3DPOS filing
Other Events
Items 8.01, 9.01
Submission of Matters to a Vote of Security Holders
Items 5.07
Show 5 more recent filings
DEFA14A filing
Regulation FD Disclosure
Items 7.01, 9.01
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
425 filing
Other Events
Items 8.01
Financials
FY 2024 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 1,319,341,000Source | 1,365,538,000Source | 1,437,303,000Source | 1,436,580,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 44,011,000Source | 54,097,000Source | 69,504,000Source | 53,161,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 607,560,000Source | 621,498,000Source | 647,009,000Source | 625,819,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 1,739,000Source | 1,739,000Source | 1,740,000Source | 1,740,000Source |
| Retained Earnings (Accumulated Deficit)USD | 60,248,000Source | 74,710,000Source | 100,408,000Source | 101,861,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -1,073,000Source | -2,572,000Source | -16,000Source | -10,000Source |
| Stockholders' Equity Attributable to ParentUSD | 711,781,000Source | 743,563,000Source | 789,751,000Source | 809,044,000Source |
| Additional Paid in Capital, Common StockUSD | 1,515,799,000Source | 1,516,806,000Source | 1,516,926,000Source | 1,516,926,000Source |
| Liabilities and EquityUSD | 1,319,341,000Source | 1,365,538,000Source | 1,437,303,000Source | 1,436,580,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 0Source | 477,000Source | 543,000Source | 1,197,000Source |
| Additional Financial Items | ||||
| Long-term DebtUSD | 569,850,000Source | 584,818,000Source | 609,941,000Source | 592,766,000Source |
| Redeemable Noncontrolling Interest, Equity, Carrying AmountUSD | — | — | — | 520,000Source |
cash flow · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -14,418,000Source | -25,664,000Source | -412,000Source | -22,866,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Deferred Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 3,632,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 40,290,000Source | 31,954,000Source | 43,846,000Source | 46,362,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | 1,134,000Source | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -16,142,000Source | 9,252,000Source | -6,186,000Source | -6,749,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | 0Source | 0Source | -291,000Source | -35,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | — | — | — | 0Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -34,423,000Source | -58,892,000Source | -21,767,000Source | -47,943,000Source |
| Dividends paid | — | — | — | — |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | 0Source | 39,000Source | -116,000Source | -159,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -10,275,000Source | -17,686,000Source | 15,893,000Source | -8,330,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 41,209,000Source | 34,900,000Source | 17,020,000Source | 17,615,000Source |
| Income Taxes Paid, NetUSD | 823,000Source | 687,000Source | 801,000Source | 690,000Source |
| Additional Financial Items | ||||
| Amortization of Debt Issuance CostsUSD | 5,221,000Source | 2,440,000Source | 2,769,000Source | 2,193,000Source |
| Amortization of Intangible AssetsUSD | — | 1,100,000Source | 3,500,000Source | 400,000Source |
| DepreciationUSD | 50,600,000Source | 50,100,000Source | — | — |
| Equity Method Investment, Realized Gain (Loss) on DisposalUSD | 0Source | 0Source | 8,376,000Source | — |
| Gain (Loss) on Disposition of Real Estate, Discontinued OperationsUSD | — | — | — | 0Source |
| Gain (Loss) on Sale of PropertiesUSD | 0Source | 0Source | 6,282,000Source | 0Source |
| Gain (Loss) on Extinguishment of DebtUSD | 0Source | -131,000Source | -28,000Source | -43,000Source |
| Gains (Losses) on Sales of Investment Real EstateUSD | 0Source | 0Source | 6,282,000Source | 0Source |
| General and Administrative ExpenseUSD | 8,759,000Source | 9,101,000Source | 10,209,000Source | 9,116,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | -25,664,000Source | -412,000Source | -22,856,000Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | 0Source | 0Source | -10,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | 0Source | 0Source | 471,000Source |
| Income Tax Expense (Benefit)USD | 611,000Source | 560,000Source | 540,000Source | 4,174,000Source |
| Net Income (Loss) Attributable to ParentUSD | -14,462,000Source | -25,698,000Source | -1,453,000Source | -22,882,000Source |
| Nonoperating Income (Expense)USD | -44,717,000Source | -38,760,000Source | -8,742,000Source | -18,505,000Source |
| Operating Lease, Lease IncomeUSD | 27,298,000Source | — | — | — |
income statement · annual statements
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Total RevenueUSD | 338,662,000Source | 314,560,000Source | 295,799,000Source | 265,321,000Source |
| Operating Income (Loss)USD | 30,910,000Source | 13,656,000Source | 8,870,000Source | -177,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -13,807,000Source | -25,104,000Source | 128,000Source | -18,682,000Source |
| Income Tax Expense (Benefit)USD | 611,000Source | 560,000Source | 540,000Source | 4,174,000Source |
| Net Income (Loss) Attributable to ParentUSD | -14,462,000Source | -25,698,000Source | -1,453,000Source | -22,882,000Source |
| Earnings Per Share, BasicUSD per share | -0.08Source | — | — | — |
| Earnings Per Share, DilutedUSD per share | -0.08Source | — | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 173,942,000Source | 173,958,000Source | 173,960,000Source | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 173,942,000Source | 173,958,000Source | 173,960,000Source | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | — | 1,100,000Source | 3,500,000Source | 400,000Source |
| Common Stock, Dividends, Per Share, DeclaredUSD per share | 0.1Source | 0.1Source | 0.1Source | 0.2Source |
| Costs and ExpensesUSD | 335,050,000Source | 327,824,000Source | 320,073,000Source | 295,599,000Source |
| Current Income Tax Expense (Benefit)USD | 611,000Source | 560,000Source | 540,000Source | -542,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 50,689,000Source | 51,234,000Source | 54,242,000Source | 50,417,000Source |
| Direct Costs of Leased and Rented Property or EquipmentUSD | 245,537,000Source | 235,524,000Source | 226,845,000Source | 197,562,000Source |
| Gains (Losses) on Sales of Investment Real EstateUSD | 0Source | 0Source | 6,282,000Source | 0Source |
| General and Administrative ExpenseUSD | 8,759,000Source | 9,101,000Source | 10,209,000Source | 9,116,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | -25,664,000Source | -412,000Source | -22,856,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | -0.15Source | -0.01Source | — |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | -0.15Source | -0.01Source | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | 0Source | 0Source | -10,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | 0Source | 0Source | 471,000Source |
| Nonoperating Income (Expense)USD | -44,717,000Source | -38,760,000Source | -8,742,000Source | -18,505,000Source |
| Operating Lease, Lease IncomeUSD | 27,298,000Source | — | — | — |
Filing attachments
d120537dex991.htm · 8-K · 2026-03-09
EX-99.1 3 d120537dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 FINANCIAL STATEMENTS INDEX TO CONSOLIDATED FINANCIAL STATEMENTS CNL HEALTHCARE PROPERTIES, INC. AND SUBSIDIARIES Page Report of Independent Registered Public Accounting Firm (PCAOB ID 238) 2 Consolidated Balance Sheets 4 Consolidated Statements of Operations …
Read attachment ↗d70626dex991.htm · 8-K · 2026-03-03
EX-99.1 2 d70626dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Company Update & State of Seniors Housing Isle at Cedar Ridge LaPorte Cancer Center ® FOR BROKER DEALER / RIA SERVICING REPS USE ONLY © 2026 CNL Healthcare Corp. All Rights Reserved. CNL and the Squares Within Squares design trademarks are used under license from CNL Intellectual Properties, Inc. CHP-0326-5266069-BD Presenters Stephen H. Mauldin John McRae CEO and President of CNL Chief Investment Officer Healthcare Properties CNL Hea…
Read attachment ↗d93400dex991.htm · 8-K · 2026-02-17
EX-99.1 2 d93400dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Re: Updated Net Asset Valuation as of Nov. 5, 2025 and Regular Distributions Feb. 17, 2026 Dear Fellow Shareholder, I am writing to inform you of an updated estimated net asset value (NAV) per share1 for the Company’s common stock as of Nov. 4, 2025. As you will recall, on Nov. 4, 2025, the Company signed a definitive transaction agreement with Sonida Senior Living, Inc. (Sonida or NYSE: SNDA), pursuant to which the Company will be…
Read attachment ↗d93400dex992.htm · 8-K · 2026-02-17
EX-99.2 3 d93400dex992.htm EX-99.2 EX-99.2 Exhibit 99.2 FA Email Subject: CNL Healthcare Properties Announces Updated Estimated NAV Results & Regular Distribution Feb. 17, 2026 FOR BROKER-DEALER AND RIA USE ONLY. Dear Financial Professional, CNL Healthcare Properties (the Company) filed a Form 8-K on Feb. 17, 2026, to announce an updated estimated net asset value (NAV) per share of $6.90 for its common stock as of Nov. 4, 2025. 1 Updated Estimated NAV On Nov. 4, 2025, the Company …
Read attachment ↗d749489dex991.htm · 8-K · 2026-01-14
EX-99.1 2 d749489dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Jan. 14, 2026 Dear Fellow Shareholder: Thank you for your investment in CNL Healthcare Properties (CHP). I am writing to notify you that on Jan. 12, MacKenzie Capital Management, LP (MacKenzie) launched an unsolicited mini-tender offer to purchase up to 400,000 shares of CHP common stock at a price of $4.55 per share. We ARE NOT AFFILIATED WITH MACKENZIE or its mini-tender offer. CHP is required by the Securities Exchange Act of 1…
Read attachment ↗d54580dex991.htm · 8-K · 2025-11-05
EX-99.1 5 d54580dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Re: Transaction Agreement and Liquidity Opportunity Nov. 5, 2025 Dear Fellow Shareholder, I am pleased to share the important news that CNL Healthcare Properties (CHP) has signed a definitive transaction agreement with Sonida Senior Living, Inc. (Sonida or SNDA), a publicly traded company on the NYSE trading under the ticker symbol “SNDA.” This agreement has been unanimously approved by our Board of Directors (Board), as well as th…
Read attachment ↗